U. S. Naval Medical Research Unit No 6, Lima, Peru.
Hospital Regional de Loreto, Loreto, Peru.
Am J Trop Med Hyg. 2019 Mar;100(3):529-531. doi: 10.4269/ajtmh.18-0802.
Here we report the first incidence of New Delhi metallo-β-lactamase (NDM-1)-producing in Peru, identified via a strain-based nosocomial surveillance project carried out in Lima and Iquitos. The gene was detected by multiplex polymerase chain reaction (PCR) and confirmed by loci sequencing. is a nearly ubiquitous and promiscuous nosocomial pathogen, and the acquisition of by may facilitate an increase in the prevalence of this important resistance marker in other nosocomial pathogens.
我们在此报告了首例在秘鲁发现的新德里金属β-内酰胺酶（NDM-1）产生的 ，该菌株是通过在利马和伊基托斯开展的基于菌株的医院感染监测项目发现的。通过多重聚合酶链反应（PCR）检测到 基因，并通过基因座测序进行了确认。 是一种几乎无处不在且混杂的医院病原体，而 获得 可能会促进其他医院病原体中这种重要耐药标记物的流行率增加。
